TickerFactsScreenerDevelopers

SANGAMO THERAPEUTICS, INC (SGMO) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2008: $19.41M2009: $21.16M2010: $10.78M2011: $16.77M2012: $21.68M2013: $10.19M2014: $6.03M2015: $69.48M2016: $22.06M2017: $49.83M2018: $140.42M2019: $80.43M2020: $131.33M2021: $178.87M2022: $100.44M2023: $45.20M2024: $41.92M2025: $20.95M$20.95M
2008Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$20.95M-50.0%
2024$41.92M-7.3%
2023$45.20M-55.0%
2022$100.44M-43.8%
2021$178.87M+36.2%
2020$131.33M+63.3%
2019$80.43M-42.7%
2018$140.42M+181.8%
2017$49.83M+125.9%
2016$22.06M-68.2%
2015$69.48M+1052.3%
2014$6.03M-40.8%
2013$10.19M-53.0%
2012$21.68M+29.3%
2011$16.77M+55.5%
2010$10.78M-49.0%
2009$21.16M+9.0%
2008$19.41M—